Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome

Yigal Abramowitz1, Yoshio Kazuno1, Tarun Chakravarty1

  • 1The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

European Heart Journal
|January 1, 2017
PubMed

Insights

Mitral annular calcification (MAC) affects nearly half of patients undergoing transcatheter aortic valve replacement (TAVR). Severe MAC independently predicts higher mortality and pacemaker implantation post-TAVR, necessitating its inclusion in risk models.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • Mitral annular calcification (MAC) shares etiological and pathophysiological links with aortic stenosis (AS).
  • MAC is commonly observed in computed tomography (CT) scans before transcatheter aortic valve replacement (TAVR).
  • The prognostic significance of MAC in TAVR patients remains under-investigated.

Purpose of the Study:

  • To determine the prevalence of MAC in patients with severe AS undergoing TAVR.
  • To evaluate the clinical impact of MAC on outcomes during and after TAVR.

Main Methods:

  • A cohort of 761 patients undergoing TAVR was analyzed.
  • Patients were stratified based on the presence and severity of MAC identified in pre-TAVR CT scans.
  • Multivariable survival analysis was employed to assess predictors of mortality and complications.

Main Results:

  • MAC was present in 49.3% of patients; severe MAC was identified in 9.5%.
  • Thirty-day mortality and major complications did not differ significantly between patients with and without MAC.
  • Severe MAC independently predicted increased all-cause and cardiovascular mortality (HR 1.95 and 2.35, respectively).
  • Severe MAC also predicted the need for permanent pacemaker implantation (PPI) post-TAVR (OR 2.83).

Conclusions:

  • MAC is highly prevalent in patients with severe AS evaluated for TAVR.
  • Severe MAC is a significant independent predictor of adverse outcomes, including mortality and conduction abnormalities.
  • Incorporating MAC assessment into TAVR risk stratification models is recommended.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
731
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
399
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.0K